Status:

NOT_YET_RECRUITING

Effects of Customized Insoles for Individuals With Symptomatic Hallux Valgus

Lead Sponsor:

Universidade Federal do Rio Grande do Norte

Conditions:

Hallux Valgus

Foot Diseases

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Hallux valgus is one of the most common forefoot deformities. Its prevalence increases with age, representing approximately 23% in adulthood, being more common in females. Some studies indicate that t...

Detailed Description

This is a protocol for a randomized, controlled, blinded clinical trial. Eighty participants with hallux valgus pain will be evaluated and randomized into two intervention groups (40 per group): custo...

Eligibility Criteria

Inclusion

  • Individuals of both sexes aged over 18 years;
  • Presence of mild to moderate hallux valgus, according to the Manchester scale;
  • Presenting no hallux with intensity greater than or equal to 3 points up to 8 points, according to the Numerical Pain Scale (END);
  • Be available to actively use the insole for at least 4 hours/day;
  • Commitment to wear closed shoes, for example (sneakers, shoes used by the patient, due to: wide toe cap and heel height of 2 to 3 cm) during the study.

Exclusion

  • Being in physical therapy treatment for hallux valgus concomitantly with the research;
  • Previous hallux valgus surgeries performed in the last 5 years;
  • Presence of foot wounds and wounds, dislocations or metatarsophalangeal fractures in the foot with HV, in the last 5 years
  • Presence of diseases such as rheumatoid arthritis, decompensated diabetes, gout, neurodegenerative diseases;
  • Cognitive and mental disorder being unable to respond; those related to the study

Key Trial Info

Start Date :

August 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT05408156

Start Date

August 1 2025

End Date

June 1 2026

Last Update

May 21 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Marcelo Cardoso de Souza

Natal, Rio Grande do Norte, Brazil, 59200-000